Cigna Group $CI Shares Purchased by Robeco Institutional Asset Management B.V.
by Scott Moore · The Cerbat GemRobeco Institutional Asset Management B.V. boosted its holdings in Cigna Group (NYSE:CI – Free Report) by 80.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 95,329 shares of the health services provider’s stock after acquiring an additional 42,641 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Cigna Group were worth $27,479,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Pathway Financial Advisers LLC raised its holdings in shares of Cigna Group by 2.3% in the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after purchasing an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. increased its holdings in shares of Cigna Group by 17.7% in the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares in the last quarter. Central Pacific Bank Trust Division lifted its position in shares of Cigna Group by 1.0% during the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after acquiring an additional 35 shares during the last quarter. HM Payson & Co. boosted its stake in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after acquiring an additional 35 shares in the last quarter. Finally, Carr Financial Group Corp grew its holdings in shares of Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after acquiring an additional 36 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.
Insider Activity at Cigna Group
In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.70% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
CI has been the subject of a number of recent analyst reports. The Goldman Sachs Group decreased their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Wells Fargo & Company decreased their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a report on Wednesday, November 5th. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Finally, Guggenheim reissued a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research note on Tuesday, December 2nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $333.04.
Get Our Latest Report on Cigna Group
Cigna Group Stock Performance
Shares of NYSE CI opened at $279.05 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The business’s 50-day moving average price is $270.88 and its two-hundred day moving average price is $289.43. The company has a market capitalization of $74.54 billion, a P/E ratio of 12.31, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the company earned $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s payout ratio is currently 26.64%.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).